Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM

Autologous stem cell transplantation (ASCT) followed by lenalidomide maintenance therapy is the standard of care for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). Clinical trials show progression-free survival (PFS) benefits, with some studies (Cancer and Leukemia Group...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Jagannath, Sundar, Abonour, Rafat, Durie, Brian G. M., Narang, Mohit, Terebelo, Howard R., Gasparetto, Cristina J., Toomey, Kathleen, Hardin, James W., Wagner, Lynne, Agarwal, Amit, Srinivasan, Shankar, Kitali, Amani, Flick, E. Dawn, Sturniolo, Michael, Rifkin, Robert M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2018
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6039656/
https://ncbi.nlm.nih.gov/pubmed/29986853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018017186
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak